These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

137 related articles for article (PubMed ID: 10632984)

  • 1. Impaired human ovarian follicular fluid complement function in hereditary angioedema.
    Perricone R; De Carolis C; Giacomello F; Giacomelli R; De Sanctis G; Fontana L
    Scand J Immunol; 2000 Jan; 51(1):104-8. PubMed ID: 10632984
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Complement, complement activation and anaphylatoxins in human ovarian follicular fluid.
    Perricone R; de Carolis C; Moretti C; Santuari E; de Sanctis G; Fontana L
    Clin Exp Immunol; 1990 Nov; 82(2):359-62. PubMed ID: 2242616
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Functionally active complement is present in human ovarian follicular fluid and can be activated by seminal plasma.
    Perricone R; Pasetto N; De Carolis C; Vaquero E; Piccione E; Baschieri L; Fontana L
    Clin Exp Immunol; 1992 Jul; 89(1):154-7. PubMed ID: 1628423
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Studies of complement autoactivatability in hereditary angioedema: direct relationship to functional C-1-INA and the effect of classical pathway activators.
    Ghebrehiwet B; Randazzo BP; Kaplan AP
    Clin Immunol Immunopathol; 1984 Jul; 32(1):101-10. PubMed ID: 6733980
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Hereditary angioedema with normal C1-inhibitor activity in women.
    Bork K; Barnstedt SE; Koch P; Traupe H
    Lancet; 2000 Jul; 356(9225):213-7. PubMed ID: 10963200
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Hereditary angioedema. A hereditary disorder in the synthesis of the complement system].
    Vanderstock L; Vander Eecken P; Vermeersch H
    Acta Otorhinolaryngol Belg; 1983; 36(3):418-31. PubMed ID: 6613563
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Complement component analysis in angiodema. Diagnostic value.
    Brasher GW; Starr JC; Hall FF; Spiekerman AM
    Arch Dermatol; 1975 Sep; 111(9):1140-2. PubMed ID: 1167046
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cystic ovaries in women affected with hereditary angioedema.
    Perricone R; Pasetto N; De Carolis C; Vaquero E; Noccioli G; Panerai AE; Fontana L
    Clin Exp Immunol; 1992 Dec; 90(3):401-4. PubMed ID: 1333923
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Complement profile in a C1 inhibitor deficient family.
    Sayama K; Shiraishi S; Miki Y
    Br J Dermatol; 1985 Dec; 113(6):737-43. PubMed ID: 4096884
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effect of plicatic acid on human serum complement includes interference with C1 inhibitor function.
    Giclas PC
    J Immunol; 1982 Jul; 129(1):168-72. PubMed ID: 6979566
    [TBL] [Abstract][Full Text] [Related]  

  • 11. C3 is activated in hereditary angioedema, and C1/C1-inhibitor complexes rise during physical stress in untreated patients.
    Nielsen EW; Johansen HT; Gaudesen O; Osterud B; Olsen JO; Høgåsen K; Hack CE; Mollnes TE
    Scand J Immunol; 1995 Dec; 42(6):679-85. PubMed ID: 8552992
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Hereditary angioedema: clinical and laboratory aspects of 7 cases].
    Moschione-Castro AP; Croce J; Diogo CL; Jacob CM; Pastorino AC; Kirschfink M; Grumach AS
    Rev Hosp Clin Fac Med Sao Paulo; 1998; 53(1):21-5. PubMed ID: 9659739
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Hereditary angioedema: therapeutic effect of danazol on C4 and C1 esterase inhibitors.
    Fabiani JE; Paulin P; Simkin G; Leoni J; Palombarani S; Squiquera L
    Ann Allergy; 1990 Apr; 64(4):388-92. PubMed ID: 2108593
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Acquired angioedema and hypocompleentemia in a patient with myelofibrosis. Effect of danazol treatment.
    Nilsen A; Matre R
    Acta Med Scand; 1980; 207(1-2):123-5. PubMed ID: 6899952
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Demonstration of modified inactive first component of complement (C1) inhibitor in the plasmas of C1 inhibitor-deficient patients.
    Zuraw BL; Curd JG
    J Clin Invest; 1986 Aug; 78(2):567-75. PubMed ID: 3734104
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Hereditary angioedema: diagnosis and management.
    Chng HH; Boey ML
    Singapore Med J; 1990 Apr; 31(2):177-9. PubMed ID: 2371584
    [TBL] [Abstract][Full Text] [Related]  

  • 17. C1-inhibitor (C1-INH) autoantibodies in hereditary angioedema. Strong correlation with the severity of disease in C1-INH concentrate naïve patients.
    Varga L; Széplaki G; Visy B; Füst G; Harmat G; Miklós K; Németh J; Cervenak L; Karádi I; Farkas H
    Mol Immunol; 2007 Feb; 44(6):1454-60. PubMed ID: 16750855
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The value of rocket immunoelectrophoresis for C4 activation in the evaluation of patients with angioedema or C1-inhibitor deficiency.
    Zuraw BL; Sugimoto S; Curd JG
    J Allergy Clin Immunol; 1986 Dec; 78(6):1115-20. PubMed ID: 3782676
    [TBL] [Abstract][Full Text] [Related]  

  • 19. C1q levels in hereditary angioedema.
    Brasher GW
    J Allergy Clin Immunol; 1977 Mar; 59(3):263-5. PubMed ID: 838995
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Response of variant hereditary angioedema phenotypes to danazol therapy. Genetic implications.
    Gadek JE; Hosea SW; Gelfand JA; Frank MM
    J Clin Invest; 1979 Jul; 64(1):280-6. PubMed ID: 376558
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.